Narcan in Da House
Yes, some of the corporations who helped fuel the opioid overdose epidemic will now be able to profit from selling us an important part of the solution
Select Page
Sometimes it’s new information. Sometimes it’s helpful, hopeful news. And sometimes it’s clickbait, bad information or useless.
by C. Scott McMillin | Sep 18, 2023 | In the News | 0 |
Yes, some of the corporations who helped fuel the opioid overdose epidemic will now be able to profit from selling us an important part of the solution
by C. Scott McMillin | Sep 7, 2023 | In the News | 0 |
by C. Scott McMillin | Sep 4, 2023 | In the News | 0 |
by C. Scott McMillin | Aug 28, 2023 | In the News | 0 |
by C. Scott McMillin | Jul 24, 2023 | In the News | 0 |
by C. Scott McMillin | Jul 10, 2023 | In the News | 0 |
by C. Scott McMillin | Jul 6, 2023 | Addiction, In the News | 0 |
Yes, it’s horrifying to read about the exploits of addicts in the grip of addiction — it’s horrifying for many of them, too — but is it something we should use against them, for purely political advantage?
Read Moreby C. Scott McMillin | Jul 3, 2023 | In the News | 0 |
Today, the making and distributing of Captagon pills accounts for 90% or more of the foreign currency in Syrian government coffers, and $57 billion in annual revenue– far beyond the scope of Mexican cartels.
Read Moreby C. Scott McMillin | Jun 12, 2023 | In the News, Public Policy | 0 |
The so-called sober homes turned out to be dilapidated houses in and around Phoenix, offering little or nothing in the way of services and featuring plenty of drug use– even trafficking. All paid for by Medicaid, to the tune of hundreds of millions in Federal funds.
Read Moreby C. Scott McMillin | Jun 5, 2023 | In the News | 0 |
Smaller vendors and ‘boutique’ pot businesses, including many that are minority-owned, will be forced to sell up to a larger firm or shut their doors entirely.
Read Moreby C. Scott McMillin | May 15, 2023 | In the News | 0 |
So in addition to the upsurge in prescribing via telehealth, our current shortage relates to far more frequent use of the medication to treat the adult variant of ADHD.
Read Moreby C. Scott McMillin | May 1, 2023 | In the News, Public Policy | 0 |
Everyone involved seems to expect further charges to emerge, against other defendants for similar activities involving the sale of political influence.
Read Moreby C. Scott McMillin | Apr 24, 2023 | Addictive Substances, In the News | 0 |
When the trip ends, the writer acknowledges, the user may be “…throwing up or having trouble at the other end.”
Read Moreby C. Scott McMillin | Apr 20, 2023 | Addictive Substances, In the News | 0 |
Also, one of the local rags had a few Shroom House products tested and discovered, to no one’s surprise, that some had been made from synthetics. Not the ‘real thing’, after all.
Read Moreby C. Scott McMillin | Apr 13, 2023 | Addictive Substances, In the News | 0 |
The President went on to insist that Mexican-made fentanyl pills only came in blue–
Read Moreby C. Scott McMillin | Mar 23, 2023 | In the News | 0 |
Programs that treat people with significant addiction histories are always vulnerable to incidents such as this. It would be called a ‘sentinel event’, meaning one that resulted in death (or near-death).
Read Moreby C. Scott McMillin | Feb 20, 2023 | In the News | 0 |
Non-drug remedies do tend to require considerably more effort than simply firing up a vape pen or chewing an edible. Medications are popular precisely because they take effect so quickly and are less likely to interrupt our busy lifestyle.
Read Moreby C. Scott McMillin | Nov 28, 2022 | Addictive Substances, In the News | 0 |
It appears that the presence of other drugs in the fentanyl and heroin currently flooding our streets has made naloxone, the opioid antagonist that is our primary weapon against OD fatalities, far less likely to be effective.
Read More